Morgan Stanley upgrades Merck to Overweight, raises target to $179
Morgan Stanley upgrades Merck to Overweight from Equalweight and lifts its price target on Merck to $179 from $116.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.